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The heart has continuous high-energy demands required to sustain efficient contraction. This is met by the metabolism of major circulating substrates (e.g. glucose, lactate or lipids), according to availability, as the heart has a limited capacity for nutrient storage (reviewed 16). Although fatty acid (FA) oxidation rates are invariably higher than glucose oxidation rates, glucose oxidation is more energy efficient that FA oxidation (with approx. 15% more ATP/O 2 molecule). Glucose and lipids compete as oxidative substrates for the heart resulting in either a glucose-FA cycle in which lipid predominates as oxidative substrate, or a reverse glucose-FA cycle, in which lipid oxidation may be suppressed and glucose utilization favoured. In addition, cardiac fuel selection is modified in disease states. Cardiac hypertrophy and heart failure, often characterized by re-expression of fetal genes, can be associated with a preference for glycolytic glucose utilization, whereas the diabetic heart exhibits a major preference for FA as oxidative fuel (reviewed 17).
Glucose oxidation is suppressed by phosphorylation (inactivation) of the pyruvate dehydrogenase complex (PDC) by the pyruvate dehydrogenase kinases (PDKs). The heart contains 3 PDK isoforms, PDK1, PDK2 and PDK4. PDK activity in cardiac myocytes is increased in a stable manner in response to increased lipid supply, uptake and utilisation and in response to insulin deficiency (reviewed in 18). PDK upregulation is likely to contribute to cardiac "metabolic inflexibility" in diabetes (reviewed in 12), where use of glucose as a metabolic fuel is greatly diminished due to a constraint on the ability to switch to glucose oxidation (2, 17) .
A diet high in saturated fat increases cardiac PDK4 expression (8) . However, enhanced PDK4 expression in the heart is not necessarily maladaptive. Wistar rats fed on a "Western" diet, only moderately high in fat (45% of calories from fat), develop cardiac dysfunction after 8-12 months, and it was proposed that this might relect suboptimal induction of FA-responsive genes, as well as pdk4, due to inadequate activation of PPAR compared with rats provided with a diet containing 60% of calories from fat (19) . The existence of a circadian rhythm within the cardiomycyte (23) affects the responsiveness of the heart to acute circadian changes in exogenous FA (5) and also influences pdk4 expression (reviewed 22). Pressure overload-induced cardiac hypertrophy, associated with a reliance on glucose, abolishes this diurnal variation of metabolic gene expression, thereby impairing the ability of the heart to anticipate and respond to physiological alterations within its environment (23) , again a situation of metabolic inflexibility.
New research has highlighted potential mechanisms underlying altered regulation of PDKs, for example hypoxia-induced upregulation of PDK1 expression by HIF-1 (1), acute control of PDK2 by phosphorylation by the diacylglycerol (DAG)-activated and redox-sensitive protein kinase C isoform PKC (3) and PPAR and FoxO1-mediated control of PDK4 gene expression (reviewed 18). Whereas the lipo-oxidative transcription factor PPAR is activated by lipids, FoxO1 is repressed by insulin. As a consequence, cardiac PDK4 mRNA and protein expression in the heart are enhanced in starvation and diabetes (8, 20) , situations that are associated with increased systemic FA delivery and insulin deficiency or resistance. 3 PDK4 null mice have lower than normal blood glucose levels during starvation because a higher PDC activity lowers the availability of gluconeogenic substrates (9) . A further study from this group, published in a previous issue of the Journal, described the effect of a global deficiency of PDK4 on glucose homeostasis in mice maintained on a high-fat diet to induce obesity (10) . Whereas the wild-type mice showed increased PDK4 protein expression in skeletal mucele and diaphragm (although not in liver or kidney in this model), global PDK4 deficiency in this model of obesity lowered blood glucose, suggesting that increased expression of PDK4 (with the resultant suppression of glucose oxidation) in muscle in response to high-fat feeding contributes to the development of hyperglycemia in diet-induced obesity. An interesting observation was that exogenous FA inhibited glucose oxidation by diaghragms from wild-type but not PDK4 -/-mice, indicating that PDK4 is the predominant "lipid-responsive" PDK isoform. This implies that a rise in FA supply is a necessary component in the upregulation of muscle PDK4 expression and suppression of glucose oxidation.
Sidhu et al. in this issue of the Journal (15) examined the effect of complete suppression of pyruvate oxidation in heart and skeletal muscle, achieved by muscle-selective knockout of the subunit of the pyruvate dehydrogenase component of PDC under control of the heart/skeletal muscle-specific creatine kinase promoter. Knockout mice (H/SM-PDCKO) of both genders grew normally until weaning, but the transition from maternal milk (which is high-fat) to the normal high carbohydrate diet at weaning had profound effects on mortality of the homozygous males, which did not survive beyond about 7 days. Female H/SM-PDCKO mice fared better, experiencing no mortality even if weaned onto a normal high carbohydrate diet. Remarkably, male H/SM-PDCKO mice survived when weaned onto a high fat diet, but developed marked myocyte hypertrophy and left ventricular dysfunction. These outcomes reiterate those seen in mice with cardiac-specific over-expression of PPAR (myosin heavy chain [MHC-PPAR ] mice) which, in the absence of alterations in lipid-fuel delivery, exhibit increased rates of myocardial lipid uptake and oxidation and decreased rates of glucose uptake and oxidation, the latter being associated with enhanced PDK4 mRNA expression (6, 7) . Like the H/SM-PDCKO mice, MHC-PPAR mice develop a cardiomyopathy with enhanced sensitivity to ischemia (11, 14) , ventricular dysfunction (21) Use of transgenic mice that express PDK4 under control of the MHC protometer showed that selective overexpression of PDK4 in the heart markedly suppresses glucose oxidation and increases FA oxidation by isolated perfused hearts (24) . These findings support the concept that suppressing glucose oxidation "forces" fat oxidation. Despite the substantial change in substrate selection, hearts from young (8 week old) PDK4 transgenic mice showed no overt cardiomyopathy or cardiac hypertrophy suggesting that the restraint on glucose oxidation imposed by PDK4 could be over-ridden. Of interest, MHC-PDK4 mice show some residual PDC activity (about 10% that of wild type), suggesting that protection against the development of cardiomyopathy could be conferred by a relatively low level of PDC flux. Consistent with this concept, in 4 the study by Sidhu et al. (15) , heterozygous H/SM-PDCKO female mice, which express about half the normal level of PDC activity consistent with random inactivation of one of the two X chromosomes in females, survive on standard high-carbohydrate/low-fat rodent diet. Enhanced anaerobic glucose metabolism is observed in ischemia, cardiac hypertrophy, and mechanical unloading (reviewed 4). An ability to increase glucose oxidation by inhibition of FA oxidation is important for the ischemic heart because it reduces production of lactate and protons which are generated under anerobic conditions because of a mismatch between glycolysis and glucose oxidation. Thus glucose oxidation not only improves energy efficiency but also reduces cellular acidification and damage.
The findings that transgenic mice over-expressing PDK4 show no signs of cardiac hypertrophy or abnormal cardiac function, contrasting with both H/SM-PDCKO and MHC-PPAR mice, also deserves comment.
When MHC-PDK4 transgenic mice are crossed with transgenic mice expressing a constitutively active form of the calcineurin catalytic subunit (CnA) to induce cardiac hypertrophy, mice bearing both the CnA and PDK4 transgenes showed substantial fibrosis and necrosis, a reduced heart rate and increased mortality (24) .
The authors hypothesised that disturbances in contractile function can be compensated for by altered metabolism and vice versa, but simultaneous disruption of energy producing and energy consuming pathways causes cardiac maladaption and heart failure. The study of Sidhu et al. 
